全文获取类型
| 收费全文 | 162025篇 |
| 免费 | 7019篇 |
| 国内免费 | 539篇 |
专业分类
| 耳鼻咽喉 | 2658篇 |
| 儿科学 | 4784篇 |
| 妇产科学 | 3703篇 |
| 基础医学 | 21855篇 |
| 口腔科学 | 5765篇 |
| 临床医学 | 10424篇 |
| 内科学 | 39364篇 |
| 皮肤病学 | 5217篇 |
| 神经病学 | 13027篇 |
| 特种医学 | 3649篇 |
| 外国民族医学 | 2篇 |
| 外科学 | 19319篇 |
| 综合类 | 1026篇 |
| 一般理论 | 45篇 |
| 预防医学 | 16022篇 |
| 眼科学 | 3501篇 |
| 药学 | 11411篇 |
| 中国医学 | 923篇 |
| 肿瘤学 | 6888篇 |
出版年
| 2023年 | 1067篇 |
| 2022年 | 1836篇 |
| 2021年 | 4459篇 |
| 2020年 | 2238篇 |
| 2019年 | 4227篇 |
| 2018年 | 5996篇 |
| 2017年 | 3557篇 |
| 2016年 | 3435篇 |
| 2015年 | 3838篇 |
| 2014年 | 5134篇 |
| 2013年 | 7332篇 |
| 2012年 | 11369篇 |
| 2011年 | 12253篇 |
| 2010年 | 6501篇 |
| 2009年 | 5046篇 |
| 2008年 | 9315篇 |
| 2007年 | 9800篇 |
| 2006年 | 9094篇 |
| 2005年 | 9048篇 |
| 2004年 | 8064篇 |
| 2003年 | 7473篇 |
| 2002年 | 6958篇 |
| 2001年 | 4507篇 |
| 2000年 | 5050篇 |
| 1999年 | 3977篇 |
| 1998年 | 879篇 |
| 1997年 | 687篇 |
| 1996年 | 580篇 |
| 1995年 | 495篇 |
| 1994年 | 398篇 |
| 1993年 | 320篇 |
| 1992年 | 1541篇 |
| 1991年 | 1277篇 |
| 1990年 | 1162篇 |
| 1989年 | 953篇 |
| 1988年 | 839篇 |
| 1987年 | 776篇 |
| 1986年 | 775篇 |
| 1985年 | 666篇 |
| 1984年 | 483篇 |
| 1983年 | 404篇 |
| 1979年 | 447篇 |
| 1975年 | 313篇 |
| 1974年 | 395篇 |
| 1973年 | 398篇 |
| 1972年 | 339篇 |
| 1971年 | 369篇 |
| 1970年 | 327篇 |
| 1969年 | 358篇 |
| 1968年 | 313篇 |
排序方式： 共有10000条查询结果，搜索用时 0 毫秒
21.
22.
Yolanda Carrascal PhD Gregorio Laguna PhD Miriam Blanco MD Bárbara Segura MD Iciar Martínez-Almeida MD 《Journal of cardiac surgery》2020,35(2):457-459
Gray platelet syndrome (GPS) is a rare (<1/1 000 000) and inherited platelet function disorder characterized by macrothrombocytopenia, α-granule deficiency, and hemorrhages. Bleeding intensity does not correlate with platelet count nor with functional test results. We hereby describe the perioperative bleeding prevention and management of a patient with GPS requiring multiple redo cardiac surgeries. 相似文献
23.
Ángela M. Ortega-Galán M. Dolores Ruiz-Fernández Rocío Ortiz-Amo José Cabrera-Troya Inés M. Carmona-Rega Olivia Ibáñez-Masero 《Enfermería clínica》2019,29(1):10-17
Objective
To discover the experiences of end-of-life patients attended by the emergency services, through the discourse of the family caregivers who accompanied the family member in this care transit.Method
A qualitative approach study, based on the paradigm of hermeneutical phenomenology. In total, 81 family caregivers participated. The techniques used were the in-depth interview and the discussion group, with a total of 5 discussion groups and 41 interviews. The period of data collection was carried out between January 2013 and June 2014.Results
In the network of discourses obtained with respect to “Urgent Care”, all the codes were grouped in relation to a single argumentative line: deficiencies in urgent care. Among them, we found different dimensions that are established depending on the different times of care, or the different determinant aspects of these deficiencies: disorganization of the care received, lack of experience of the professionals in emergencies, application of general protocols in the emergency services, inadequate care in the treatment received, delays in emergency care.Conclusions
In general, we highlight the dissatisfaction of the family members with respect to the care received from the emergency services. The needs of these types of situation are not covered from these services and are of low quality. Therefore, it is necessary to reorient the care protocols for these patients. 相似文献24.
José A. Lorente Pablo Cardinal-Fernández Diego Muñoz Fernando Frutos-Vivar Arnaud W. Thille Carlos Jaramillo Aida Ballén-Barragán José M. Rodríguez Oscar Peñuelas Guillermo Ortiz José Blanco Bruno Valle Pinheiro Nicolás Nin María del Carmen Marin Andrés Esteban Taylor B. Thompson 《Intensive care medicine》2015,41(11):1921-1930
25.
26.
27.
28.
Selcen Yuksel Selim Ayhan Vugar Nabiyev Montse Domingo-Sabat Alba Vila-Casademunt Ibrahim Obeid Francisco Sanchez Perez-Grueso Emre Acaroglu 《The spine journal》2019,19(1):71-78
BACKGROUND CONTEXT
Health-related quality of life (HRQOL) parameters have been shown to be reliable and valid in patients with adult spinal deformity (ASD). Minimum clinically important difference (MCID) has become increasingly important to clinicians in evaluating patients with a threshold of improvement that is clinically relevant.PURPOSE
To calculate MCID and minimum detectable change (MDC) values of total scores of the Core Outcome Measures Index (COMI), Oswestry Disability Index (ODI), Physical Component Summary (PCS), Mental Component Summary (MCS) of the Short Form 36 (SF-36), and Scoliosis Research Society 22R (SRS-22R) in surgically and nonsurgically treated ASD patients who have completed an anchor question at pretreatment and 1-year follow-up.STUDY DESIGN/SETTING
Prospective cohort.PATIENT SAMPLE
Surgical and nonsurgical patients from a multicenter ASD database.OUTCOME MEASURES
Self-reported HRQOL measures (COMI, ODI, SF-36, SRS-22R, and anchor question).METHODS
A total of 185 surgical and 86 nonsurgical patients from a multicenter ASD database who completed pretreatment and 1-year follow-up HRQOL scales and the anchor question at the first year follow-up were included. The anchor question was used to determine MCID for each HRQOL measure. MCIDs were calculated by an anchor-based method using latent class analysis (LCA) and MDCs by a distribution-based method.RESULTS
All differences between means of baseline and first year postoperative total score measures for all scales demonstrated statistically significant improvements in the overall population as well as the surgically treated patients but not in the nonsurgical group. The calculated MDC and MCID values of HRQOL parameters in the entire study population were 1.34 and 2.62 for COMI, 10.65 and 14.31 for ODI, 6.09 and 7.33 for SF-36 PCS, 6.14 and 4.37 for SF-36 MCS, and 0.42 and 0.71 for SRS-22R. The calculated MCID values for surgical and non-surgical treatment groups were 2.76 versus 1.20 for COMI, 14.96 versus 2.45 for ODI, 7.83 versus 2.15 for SF-36 PCS, 5.14 versus 2.03 for SF-36 MCS, and 0.94 versus 0.11 for SRS-22R; the MDC values for surgical and nonsurgical treatment groups were 1.22 versus 1.51 for COMI, 10.27 versus 9.45 for ODI, 5.16 versus 6.77 for SF-36 PCS, 6.05 versus 5.67 for SF-36 MCS, and 0.38 versus 0.43 for SRS-22R.CONCLUSIONS
This study has demonstrated that MCID calculations for the HRQOL scales in ASD using LCA yield values comparable to other studies that had used different methodologies. The most important finding was the significantly different MCIDs for COMI, ODI, SF-36 PCS and SRS-22 in the surgically and nonsurgically treated cohorts. This finding suggests that a universal MCID value, inherent to a specific HRQOL for an entire cohort of ASD may not exist. Use of different MCIDs for surgical and nonsurgical patients may be warranted. 相似文献29.
Miguel A. Sanz Pau Montesinos Haesook T. Kim Guillermo J. Ruiz-Argüelles María S. Undurraga María R. Uriarte Lem Martínez Rafael H. Jacomo Homero Gutiérrez-Aguirre Raul A. M. Melo Rosane Bittencourt Ricardo Pasquini Katia Pagnano Evandro M. Fagundes Edo Vellenga Alexandra Holowiecka Ana J. González-Huerta Pascual Fernández Javier De la Serna Salut Brunet Elena De Lisa José González-Campos José M. Ribera Isabel Krsnik Arnold Ganser Nancy Berliner Raul C. Ribeiro Francesco Lo-Coco Bob L?wenberg Eduardo M. Rego 《Annals of hematology》2015,94(8):1347-1356
30.